Delivered 8% sales growth and 21% adjusted EPS growth in full year 2025 ~ ~ 2026 Outlook maintains midpoint of sales growth and high end of ...

BioNTech SE is transitioning from a COVID-19 vaccine story to a late-stage oncology platform with a robust $17B cash position. Click to read why BNTX is a Buy.

Q4 2025 Earnings Call February 25, 2026 9:00 AM ESTCompany ParticipantsMussannah ChowdhuryOliver Quinn - President, CEO ...

Exceptional order momentum with Order Intake in Q4 2025 increasing 46% vs Q4 2024, Order Backlog further grew to a multi-year record high of over ...

UMH Properties, Inc. (NYSE:UMH) (TASE:UMH) reported Total Income of $261.8 million for the year ended December 31, 2025 as compared to $240.6 million for the year ended December 31, 2024, representing ...

Guidance reaffirmed -- Fiscal year 2026 revenue expected to be flat to down 2% and adjusted EBITDA forecast at $285 million ...

Realty Income Corporation (Realty Income, NYSE: O), The Monthly Dividend Company®, today announced operating results for the ...

Remitly Global, Inc. (NASDAQ:RELY) Q4 2025 Earnings Call Transcript February 19, 2026 Operator: Good day, and thank you for ...

Oscar Health, Inc. (NYSE:OSCR) Q4 2025 Earnings Call Transcript February 10, 2026 Oscar Health, Inc. misses on earnings expectations. Reported EPS is $-1.24489 EPS, expectations were $-0.9214.

Fourth Quarter Financial Highlights. Subscriptions revenue increased 6% year-over-year to $622 million. Total revenue increased 5% year-over-year to $644 million. GAAP operating m ...

Exceptional order momentum with Order Intake in Q4 2025 increasing 46% vs Q4 2024, Order Backlog further grew to a multi-year record high of over $1.2b, providing a solid basis for 2026 growthStrong N ...

Vestis Corporation (NYSE:VSTS) Q1 2026 Earnings Call Transcript February 10, 2026 Vestis Corporation beats earnings expectations. Reported EPS is $0.1, expectations were $0.06. Operator: Thank you for ...